BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 18066963)

  • 1. Current CHS and NHBPEP criteria for severe preeclampsia do not uniformly predict adverse maternal or perinatal outcomes.
    Menzies J; Magee LA; Macnab YC; Ansermino JM; Li J; Douglas MJ; Gruslin A; Kyle P; Lee SK; Moore MP; Moutquin JM; Smith GN; Walker JJ; Walley KR; Russell JA; von Dadelszen P
    Hypertens Pregnancy; 2007; 26(4):447-62. PubMed ID: 18066963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are maternal and fetal parameters related to perinatal mortality in HELLP syndrome?
    Guzel AI; Kuyumcuoglu U; Celik Y
    Arch Gynecol Obstet; 2011 Jun; 283(6):1227-32. PubMed ID: 20526778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perinatal outcomes in severe preeclampsia-eclampsia with and without HELLP syndrome.
    Gul A; Cebeci A; Aslan H; Polat I; Ozdemir A; Ceylan Y
    Gynecol Obstet Invest; 2005; 59(2):113-8. PubMed ID: 15591806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute kidney injury associated with preeclampsia or hemolysis, elevated liver enzymes, and low platelets syndrome.
    Novotny S; Lee-Plenty N; Wallace K; Kassahun-Yimer W; Jayaram A; Bofill JA; Martin JN
    Pregnancy Hypertens; 2020 Jan; 19():94-99. PubMed ID: 31927326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early risk assessment of severe preeclampsia: admission battery of symptoms and laboratory tests to predict likelihood of subsequent significant maternal morbidity.
    Martin JN; May WL; Magann EF; Terrone DA; Rinehart BK; Blake PG
    Am J Obstet Gynecol; 1999 Jun; 180(6 Pt 1):1407-14. PubMed ID: 10368478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormal liver function tests as predictors of adverse maternal outcomes in women with preeclampsia.
    Kozic JR; Benton SJ; Hutcheon JA; Payne BA; Magee LA; von Dadelszen P;
    J Obstet Gynaecol Can; 2011 Oct; 33(10):995-1004. PubMed ID: 22014776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteinuria in pre-eclampsia: how much matters?
    Chan P; Brown M; Simpson JM; Davis G
    BJOG; 2005 Mar; 112(3):280-5. PubMed ID: 15713140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [HELLP syndrome: a rare, threatening complication in pre-eclampsia].
    Dadak C; Feiks A; Lasnik E
    Geburtshilfe Frauenheilkd; 1986 Sep; 46(9):637-9. PubMed ID: 3770412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical course of premature and newborn infants of mothers with HELLP syndrome].
    Nikischin W; Conradt A; Schröder H
    Z Geburtshilfe Perinatol; 1991; 195(1):16-20. PubMed ID: 2053379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Moderate to severe thrombocytopenia during pregnancy.
    Parnas M; Sheiner E; Shoham-Vardi I; Burstein E; Yermiahu T; Levi I; Holcberg G; Yerushalmi R
    Eur J Obstet Gynecol Reprod Biol; 2006; 128(1-2):163-8. PubMed ID: 16533554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical outcomes and characteristics of concurrent eclampsia and hemolysis, elevated liver enzymes, and low platelets syndrome].
    DI XD; Chen DJ; Liu HS; Kuang JL; Huang DJ
    Zhonghua Fu Chan Ke Za Zhi; 2010 Oct; 45(10):740-4. PubMed ID: 21176553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preeclampsia/eclampsia with hemolysis, elevated liver enzymes, and thrombocytopenia.
    Weinstein L
    Obstet Gynecol; 1985 Nov; 66(5):657-60. PubMed ID: 4058824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using clinical symptoms to predict adverse maternal and perinatal outcomes in women with preeclampsia: data from the PIERS (Pre-eclampsia Integrated Estimate of RiSk) study.
    Yen TW; Payne B; Qu Z; Hutcheon JA; Lee T; Magee LA; Walters BN; von Dadelszen P;
    J Obstet Gynaecol Can; 2011 Aug; 33(8):803-809. PubMed ID: 21846435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The spectrum of severe preeclampsia: comparative analysis by HELLP (hemolysis, elevated liver enzyme levels, and low platelet count) syndrome classification.
    Martin JN; Rinehart BK; May WL; Magann EF; Terrone DA; Blake PG
    Am J Obstet Gynecol; 1999 Jun; 180(6 Pt 1):1373-84. PubMed ID: 10368474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maternal and feto-placental phenotypes of early-onset severe preeclampsia.
    Pilliod RA; Feinberg BB; Burwick RM
    J Matern Fetal Neonatal Med; 2016; 29(8):1209-13. PubMed ID: 25983137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Analysis of the perinatal outcome and risk factors for pregnancies complicated with chronic renal diseases].
    Xie M; Zhang C; Wang JL; Wang SM; Zhang XH
    Zhonghua Fu Chan Ke Za Zhi; 2012 Mar; 47(3):161-5. PubMed ID: 22781064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The evaluation of maternal parameters at diagnosis may predict HELLP syndrome severity.
    Carpani G; Bozzo M; Ferrazzi E; D'Amato B; Pizzotti D; Radaelli T; Moroni G; Pardi G
    J Matern Fetal Neonatal Med; 2003 Mar; 13(3):147-51. PubMed ID: 12820835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Follow-up in HELLP syndrome].
    Rosen A; Klein M; Beck A
    Zentralbl Gynakol; 1990; 112(5):273-7. PubMed ID: 2353550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristic laboratory changes in pregnancies complicated by HELLP syndrome.
    Hupuczi P; Nagy B; Sziller I; Rigó B; Hruby E; Papp Z
    Hypertens Pregnancy; 2007; 26(4):389-401. PubMed ID: 18066958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between thrombophilic disorders and type of severe early-onset hypertensive disorder of pregnancy.
    Ganzevoort W; Rep A; De Vries JI; Bonsel GJ; Wolf H;
    Hypertens Pregnancy; 2007; 26(4):433-45. PubMed ID: 18066962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.